4//SEC Filing
NovaBay Pharmaceuticals, Inc. 4
Accession 0001437749-17-012378
$NBYCIK 0001389545operating
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:20 PM ET
Size
5.2 KB
Accession
0001437749-17-012378
Insider Transaction Report
Form 4
Li Xinzhou
10% OwnerOther
Transactions
- Award
stock option (right to buy)
2017-07-03+5,248→ 5,248 totalExercise: $3.75From: 2017-08-01Exp: 2027-07-03→ common stock (5,248 underlying)
Footnotes (2)
- [F1]option vests in equal installments over the next six months so that they are fully vested by Dec 31, 2017
- [F2]Granted as compensation as a director for Q3 and Q4 2017, pursuant to the 2017 Non-Employee Director Plan
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001389545
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:20 PM ET
- Size
- 5.2 KB